日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

TBK1 Targeting Is Identified as a Therapeutic Strategy to Enhance CAR T-Cell Efficacy Using Patient-Derived Organotypic Tumor Spheroids

利用患者来源的类器官肿瘤球体,TBK1靶向治疗被认为是一种增强CAR-T细胞疗效的治疗策略。

Yi Sun # ,Luke Maggs # ,Apekshya Panda ,Samuel J Wright ,Angelina M Cicerchia ,Anne Jenney ,Matthew D Perricone ,Caitlin E Mills ,Giulia Cattaneo ,Marco Ventin ,Feng Chen ,Martin Q Rasmussen ,Alex Miranda ,Or-Yam Revach ,Jacy Fang ,Amina Fu ,Peter J Bowling ,Tatyana Sharova ,Aleigha Lawless ,Peter K Sorger ,Nabeel Bardeesy ,Xinhui Wang ,Keith T Flaherty ,Genevieve M Boland ,Arnav Mehta ,Moshe Sade-Feldman ,Cristina R Ferrone ,Russell W Jenkins

MCT4-dependent lactate secretion suppresses antitumor immunity in LKB1-deficient lung adenocarcinoma

MCT4依赖性乳酸分泌抑制LKB1缺陷型肺腺癌的抗肿瘤免疫

Yu Qian ,Ana Galan-Cobo ,Irene Guijarro ,Minghao Dang ,David Molkentine ,Alissa Poteete ,Fahao Zhang ,Qi Wang ,Jing Wang ,Edwin Parra ,Apekshya Panda ,Jacy Fang ,Ferdinandos Skoulidis ,Ignacio I Wistuba ,Svena Verma ,Taha Merghoub ,Jedd D Wolchok ,Kwok-Kin Wong ,Ralph J DeBerardinis ,John D Minna ,Natalie I Vokes ,Catherine B Meador ,Justin F Gainor ,Linghua Wang ,Alexandre Reuben ,John V Heymach

Effectors Enabling Adaptation to Mitochondrial Complex I Loss in Hürthle Cell Carcinoma

效应因子使嗜酸细胞癌能够适应线粒体复合物 I 的缺失

Raj K Gopal # ,Venkata R Vantaku # ,Apekshya Panda ,Bryn Reimer ,Sneha Rath ,Tsz-Leung To ,Adam S Fisch ,Murat Cetinbas ,Maia Livneh ,Michael J Calcaterra ,Benjamin J Gigliotti ,Kerry A Pierce ,Clary B Clish ,Dora Dias-Santagata ,Peter M Sadow ,Lori J Wirth ,Gilbert H Daniels ,Ruslan I Sadreyev ,Sarah E Calvo ,Sareh Parangi ,Vamsi K Mootha